Reporting owner · CIK 0001801050
Welgus Howard G.
Visual SEC Form 4 history across 1 companies, 12 transactions and 6 filings.
DIRArcutis Biotherapeutics, Inc.
Open-market mix
0%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Jan 25
−$146.7K
Feb 25
−$127.1K
Mar 25
−$130K
Jan 26
−$289.6K
Feb 26
−$250.5K
Aug 26
−$123.8K
Transaction texture
Ownership and ticket size
Average P/S size$178K
Median P/S size$138.4K
Direct12
Indirect0
Aug 17, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Arcutis Biotherapeutics, Inc. on Aug 17, 2026 valued at $123,835.
Review SEC filingLatest buy
No open-market insider purchase is available.
Latest sale
sale at Arcutis Biotherapeutics, Inc. on Aug 17, 2026 valued at $123,835.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 2.25k | $0 | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 1.01k | $0 | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 822 | $0 | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | sale10b5-1 | 4.73k | -$12.3M | S | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 2.25k | $1.94M | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 1.01k | $765k | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | exercise10b5-1 | 822 | $536k | M | −10.2% | 08/19 | 08/17 | |
| ARQT | Welgus Howard G. | DIR | sale10b5-1 | 10.0k | -$25.0M | S | −7.3% | 02/05 | 02/02 | |
| ARQT | Welgus Howard G. | DIR | sale10b5-1 | 10.0k | -$28.9M | S | — | 01/06 | 01/02 | |
| ARQT | Welgus Howard G. | DIR | sale10b5-1 | 10.0k | -$13.0M | S | — | 03/05/2025 | 03/03/2025 |
Welgus Howard G. Insider Activity FAQ
SEC Form 4 context
Who is Welgus Howard G.?
Welgus Howard G. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001801050.
Which companies has Welgus Howard G. reported transactions for?
Arcutis Biotherapeutics, Inc.
When was Welgus Howard G.'s latest insider buy?
No open-market insider purchase is available for this period.
When was Welgus Howard G.'s latest insider sale?
sale at Arcutis Biotherapeutics, Inc. on Aug 17, 2026 valued at $123,835.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.